Brief: Onxeo Announces Approval For Delisting From Nasdaq Main Market Copenhagen

Valerio Therapeutics SA

30/11/2020 10:20

Nov 30 (Reuters) - ONXEO SA  C4X.PA :
    * HAS RECEIVED APPROVAL FOR DELISTING FROM NASDAQ MAIN
MARKET
COPENHAGEN AND CONCURRENT ADMISSION TO TRADING ON NASDAQ FIRST
NORTH GROWTH MARKET DENMARK
    * NASDAQ COPENHAGEN HAS TODAY NOTIFIED COMPANY OF THEIR
APPROVAL
OF APPLICATIONS
    * AS A RESULT LAST TRADING DAY ON NASDAQ MAIN MARKET
COPENHAGEN
WILL BE 11 DECEMBER 2020 AND FIRST DAY OF TRADING ON NASDAQ
FIRST NORTH GROWTH MARKET DENMARK WILL BE 14 DECEMBER 2020
    * PURPOSE OF BOTH TRANSFERS IS TO ALLOW ONXEO TO BE LISTED
ON A
MARKET WHICH IS MORE SUITABLE TO COMPANY'S SIZE AND ITS MARKET
CAPITALIZATION
    * TRANSFERS TO EURONEXT GROWTH PARIS AND FIRST NORTH GROWTH
MARKET
SHOULD PROVIDE COMPANY WITH A REGULATORY FRAMEWORK THAT IS
BETTER SUITED TO A SME AND REDUCE LISTING-RELATED COSTS

Source text for Eikon:  ID:nBwT3S2ha 
Further company coverage:  C4X.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))